MYLAN 6150 MYLAN 6150
Pill imprint MYLAN 6150 MYLAN 6150 has been identified as Omeprazole 20 mg.
Omeprazole is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; helicobacter pylori infection (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy.
Omeprazole 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Omeprazole Images
- Imprint:
-
MYLAN 6150
MYLAN 6150 - Strength:
- 20 mg
- Color:
- Green
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- ammonia
dibutyl sebacate
ethylcelluloses
silicon dioxide
hypromelloses
methacrylic acid
oleic acid
magnesium silicate
triethyl citrate
D&C Yellow No. 10
FD&C Green No. 3
gelatin
sodium lauryl sulfate
titanium dioxide
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6150
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0007 | UDL Laboratories Inc |
| 55887-0396 | Diversified Healthcare Services Inc (repackager) |
Note: Inactive ingredients may vary.
More Omeprazole resources
- Omeprazole
- Omeprazole Delayed-Release Capsules (Wolters Kluwer)
- Omeprazole Delayed-Release Tablets (Wolters Kluwer)
- Omeprazole Magnesium Delayed-Release Capsules (Wolters Kluwer)
- Omeprazole Suspension (Wolters Kluwer)
- omeprazole (Cerner Multum)
- omeprazole (Micromedex) - Includes Dosage Information
- Omeprazole (AHFS DI)
- Omeprazole (FDA)
- Omeprazole Tablets (FDA)
- Omesec Drug Facts (FDA)
- Omeprazole (Wolters Kluwer)


